Seegene Middle East

Seegene Middle East is a subsidiary of Seegene Inc., a leader in multiplex molecular diagnostics based in South Korea. Founded in 2000, the company specializes in developing advanced in vitro diagnostic (IVD) products, particularly molecular diagnostic assays that allow for the simultaneous detection and quantification of multiple pathogens from a single sample. Seegene Middle East serves the growing markets in the Middle East and North Africa, including the UAE, Saudi Arabia, and Egypt, by expanding distribution channels and adapting to local trends. The company utilizes proprietary technologies such as Dual Priming Oligonucleotide (DPO) and Multiple Detection Temperatures (MuDT) in its assays, which cover a wide range of infectious diseases. Seegene Middle East offers a portfolio of diagnostic kits for respiratory viruses, bacteria, and sexually transmitted diseases, with plans for further product launches. The company also develops diagnostic platforms like the All-in-One platform to enhance accessibility in clinical settings. Seegene Middle East actively participates in regional medical exhibitions to strengthen its brand presence and expand its customer base among hospitals and clinical laboratories.

• Employees 14